In the context of epidemiology, what is the denominator used for calculating incidence?
What is the term for the time between infection and maximum infectivity?
Which of the following is not classified as a special incidence rate?
Which of the following best describes the concept where a suspected cause precedes the observed effect?
Which cancer type has the most effective screening procedure?
Following are examples of human "dead end" diseases except -
Which statement best describes the concept of web of causation in disease?
What does the term 'proportional mortality rate' refer to?
Which study design is primarily used to understand the natural history of a disease?
Which of the following is considered the most basic measure of mortality?
Explanation: ***Population at risk*** - Incidence measures the **rate of new cases** of a disease in a population over a specified period. - The denominator for calculating incidence must exclude individuals who are **already diseased** or are **immune** and thus not susceptible to developing the condition. - This is the **most accurate and theoretically correct** denominator as it represents only those who can actually develop the disease. *Mid year population* - While often used as a **practical approximation** in epidemiological calculations when the exact population at risk is difficult to determine. - However, it includes individuals who may not be at risk (e.g., already have the disease or are immune), making it **less precise** than using the actual susceptible population. - For the **theoretical definition** of incidence rate, population at risk is the correct denominator. *Total number of cases* - This value represents the **numerator** for incidence calculations, as it counts the number of new events or diseases occurring. - It cannot serve as the denominator, as the denominator must reflect the pool of individuals from which these **new cases arose**. *Total number of deaths* - This is a measure of **mortality**, not incidence, and is used to calculate death rates. - The denominator for mortality rates is typically the **population at risk of death**, not specifically the population at risk of developing a disease.
Explanation: ***Generation time*** - This is the **time interval** between receipt of infection by a host and the moment of **maximum infectivity** of that same host. - It is a crucial parameter in epidemiology for understanding **disease transmission dynamics** and the speed at which an epidemic can spread. *Incubation period* - This refers to the time from **exposure to an infectious agent** until the **onset of symptoms**. - It does not directly account for the timing of viral shedding or peak infectivity. *Serial interval* - This is the time between **symptom onset in a primary case** and **symptom onset in a secondary case** it infects. - While related to transmission, it focuses on symptomatic presentation rather than peak infectivity. *Communicable period* - This is the time during which an infected individual is **capable of transmitting** the infectious agent to others. - It represents the entire duration of potential transmission, not specifically the peak infectivity.
Explanation: ***Standardized mortality rate*** - This is a measure used to compare **mortality rates** between different populations, adjusting for age or other confounding factors. - It is a **standardized mortality measure**, not an incidence rate, and therefore not classified as a special incidence rate. - Special incidence rates measure the occurrence of **new cases** in specific circumstances, whereas SMR is a **comparative mortality metric**. *Attack rate* - The **attack rate** is a classic **special incidence rate** used to describe the proportion of people in a population who became ill during an **epidemic or outbreak**. - It is specifically calculated during a **short, well-defined period**, often relevant to foodborne illnesses or infectious disease outbreaks. *Secondary attack rate* - The **secondary attack rate** is a **special incidence rate** that measures the proportion of susceptible people who develop a disease after being exposed to a **primary case** within a defined population (e.g., household contacts). - It quantifies the **spread of an infectious agent** within a closed population after its introduction. *Hospital admission rate* - This is a **health service utilization indicator** that measures hospital admissions in a population during a specified period. - It is **not classified as a special incidence rate** in standard epidemiological teaching, as it reflects healthcare utilization rather than disease occurrence in outbreak situations.
Explanation: ***Temporal association*** - This principle in **causal inference** emphasizes that for a factor to be a cause, it must precede the effect. - In epidemiology, it's crucial to establish that exposure occurred **before the disease manifestation**. *Consistency of association* - Refers to the observation of a **similar association across different studies** and populations. - While important for causal inference, it does not directly address the timing of cause and effect. *Strength of association* - Quantifies how often the **exposure and outcome co-occur**, often measured by relative risk or odds ratio. - A strong association is more likely to be causal, but it doesn't confirm that the cause came before the effect. *Coherence of association* - Implies that the observed association should be **consistent with existing biological and medical knowledge**. - This criterion supports the plausibility of an association but doesn't specifically deal with the temporal sequence.
Explanation: ***Cervical Cancer*** - **Pap smear and HPV testing** represent the most effective cancer screening program, with proven reduction of **>70% in cervical cancer incidence and mortality**. - Screening detects **pre-cancerous lesions (CIN)** during the long latent period, allowing for effective intervention before cancer develops. - Well-established guidelines with high sensitivity, specificity, and cost-effectiveness make it a **public health success story**. - Particularly relevant in Indian context where cervical cancer burden is high and screening programs are being expanded. *Colon Cancer* - **Colonoscopy** and **fecal occult blood testing (FOBT)** are highly effective, allowing direct visualization and removal of precancerous polyps. - While very effective with proven mortality reduction, screening uptake is lower and the procedure is more invasive than cervical cancer screening. - Effectiveness is comparable but cervical cancer screening has achieved greater population-level impact historically. *Prostate Cancer* - Screening with **PSA (prostate-specific antigen) testing** and **digital rectal exam (DRE)** is controversial due to potential for **overdiagnosis and overtreatment** of indolent cancers. - Impact on overall mortality reduction is debated, and it doesn't prevent cancer through detection of precancerous lesions like cervical/colon cancer screening. *Gastric Cancer* - **Gastric cancer screening** is not routinely recommended in most countries including India due to lower prevalence and lack of a highly effective, non-invasive screening method. - **Endoscopy** can detect gastric cancer but is typically performed in symptomatic individuals or high-risk populations (e.g., Japan, Korea), not as a general population screening tool.
Explanation: ***Bubonic plague (Plague)*** - The question refers to **plague in general**, which includes multiple clinical forms. - While **bubonic plague** (the most common form) is transmitted via **flea bites** from infected rodents and humans are typically dead-end hosts for this form, **pneumonic plague** (secondary complication or primary infection) allows **human-to-human transmission** via respiratory droplets. - This makes plague the **exception** among the listed diseases, as humans can serve as a source of infection to others in the pneumonic form, unlike true dead-end host situations. *Japanese encephalitis* - Humans are **dead-end hosts** for Japanese encephalitis virus. - Infected humans do not develop sufficient **viremia** to infect feeding mosquitoes. - The virus maintains its cycle between **Culex mosquitoes**, **pigs** (amplifying hosts), and **wading birds**, with humans being incidental hosts. *Hydatid disease* - Humans are **definitive dead-end hosts** for *Echinococcus granulosus* (causing cystic echinococcosis/hydatid disease). - The normal life cycle requires **definitive hosts** (dogs, canids) and **intermediate hosts** (sheep, cattle). - Humans develop **hydatid cysts** but cannot transmit the infection further as the parasite cannot complete its life cycle in humans. *Leishmaniasis* - In most forms of leishmaniasis, humans are considered **dead-end or accidental hosts**, particularly in **zoonotic cutaneous leishmaniasis** where animal reservoirs (rodents, dogs) maintain transmission. - However, in **anthroponotic visceral leishmaniasis** (*Leishmania donovani* in the Indian subcontinent), humans can serve as reservoir hosts. - For the purpose of this question, leishmaniasis is generally classified with dead-end diseases as the majority of leishmaniasis forms have zoonotic cycles where humans are incidental hosts with limited onward transmission.
Explanation: ***Considers all relevant factors associated with disease causation.*** - The **web of causation** model acknowledges that diseases often arise from a complex interplay of multiple interconnected factors, rather than a single cause. - It emphasizes that **no single factor is sufficient or necessary** for disease occurrence, but rather a combination of factors increases susceptibility or triggers the disease process. *Applicable primarily to common diseases.* - The web of causation model is a **universal concept** in epidemiology, applicable to both common and rare diseases. - Its utility lies in explaining the complex etiology of diseases regardless of their prevalence. *Focuses on epidemiological ratios.* - While epidemiological ratios (e.g., odds ratios, relative risk) measure associations between factors and disease, the **web of causation** provides a conceptual framework for understanding the *nature* of these associations. - It describes the **interconnections and causal pathways**, not just the statistical strength of association. *Aids in interrupting the transmission of diseases.* - This statement is more descriptive of **public health interventions** based on understanding disease transmission dynamics. - While insights from the **web of causation** can inform interventions, the model itself describes the *etiology* rather than directly outlining methods for interrupting transmission.
Explanation: ***The proportion of deaths due to a specific cause in relation to total deaths*** - The **proportional mortality rate** calculates the fraction of all deaths in a population attributable to a particular cause. - This metric helps to understand the relative importance of specific diseases or conditions as causes of death within a given period. *The total number of deaths in a given year* - This option describes the **crude death count** or **absolute number of deaths**, not a proportional rate. - It does not provide information about the **distribution** or **proportion** of deaths due to specific causes. *The number of deaths in a specific month* - This refers to a **monthly death count**, which is a measure of absolute frequency over a shorter period. - It does not represent a **proportion** of specified deaths compared to total deaths. *The total number of deaths regardless of cause* - This is the **total mortality count** over a specified period, typically used to calculate the **crude mortality rate** when divided by the population size. - It does not differentiate deaths by **cause** or express them as a **proportion** of the total.
Explanation: ***Cohort studies*** - **Cohort studies** follow a group of individuals over a period, allowing researchers to observe the incidence, progression, and outcomes of a disease naturally. - They are ideal for understanding the **natural history** of a disease, identifying risk factors, and assessing prognosis. - By following subjects from exposure to outcome, cohort studies reveal the temporal sequence and progression patterns of disease. *Cross-sectional studies* - **Cross-sectional studies** assess a population at a single point in time, providing a snapshot of disease prevalence and risk factor distribution. - They cannot establish temporal relationships or the natural progression of a disease because they lack follow-up over time. *Case-control studies* - **Case-control studies** compare individuals with a disease (cases) to individuals without the disease (controls) to identify past exposures or risk factors. - They are retrospective and focus on identifying potential causes of a disease *after* it has occurred, rather than observing its natural development. *Randomized controlled trials* - **Randomized controlled trials (RCTs)** are experimental studies designed to test the efficacy of interventions by randomly assigning participants to treatment or control groups. - They focus on evaluating therapeutic interventions rather than observing the natural, unmodified course of disease.
Explanation: ***Crude death rate*** - The **crude death rate** is the total number of deaths in a given period divided by the total population, making it the most basic and fundamental measure of mortality. - It provides an overall picture of mortality in a population without considering age, sex, or cause of death. *Case fatality rate* - The **case fatality rate** measures the proportion of individuals diagnosed with a specific disease who die from that disease. - It is specific to a particular condition and not a general measure of mortality for a whole population. *Proportional mortality rate* - The **proportional mortality rate** indicates the proportion of all deaths due to a specific cause. - It describes the relative importance of a specific cause of death but does not represent the actual risk of dying from that cause in the overall population. *Specific death rate* - A **specific death rate** refers to mortality rates calculated for specific population subgroups (e.g., age-specific, sex-specific, or cause-specific). - While more detailed, it is not the most basic measure as it involves stratification beyond the raw population count.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free